KAPITALSCHUTZ-ZERTIFIKAT CLASSIC - ROCHE GS/SANOFI/BASF Share Price

Certificat

DE000SR7YJH9

Market Closed - Boerse Frankfurt Warrants 12:10:41 24/05/2024 BST
985.1 EUR -0.76% Intraday chart for KAPITALSCHUTZ-ZERTIFIKAT CLASSIC - ROCHE GS/SANOFI/BASF
Current month-0.12%
1 month-2.47%
Date Price Change
24/05/24 985.1 -0.76%
23/05/24 992.6 +0.19%
22/05/24 990.7 -0.04%
21/05/24 991.1 -0.23%
20/05/24 993.4 -0.05%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 12:10 pm

More quotes

Static data

Product typeKapitalgarantie 100%
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SR7YJH
ISINDE000SR7YJH9
Date issued 19/04/2024
Strike 222.1 CHF
Maturity 19/10/2027 (1243 Days)
Parity 0.22 : 1
Emission price 1,010
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1,010
Lowest since issue 978.9
Spread 10
Spread %1.00%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
230.4 CHF
Average target price
279.8 CHF
Spread / Average Target
+21.46%
Consensus